Total Payments
$421,118
2024 Payments
$1,377
Companies
71
Transactions
895
Medicare Patients
945
Medicare Billing
$93,769
Payment Breakdown by Category
Other$269,955 (64.1%)
Consulting$72,933 (17.3%)
Travel$54,342 (12.9%)
Food & Beverage$23,322 (5.5%)
Education$565.49 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $269,955 | 75 | 64.1% |
| Consulting Fee | $72,933 | 20 | 17.3% |
| Travel and Lodging | $54,342 | 123 | 12.9% |
| Food and Beverage | $23,322 | 663 | 5.5% |
| Education | $565.49 | 14 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INSYS Therapeutics Inc | $188,568 | 127 | $0 (2018) |
| Verastem, Inc. | $78,849 | 73 | $0 (2020) |
| Genentech USA, Inc. | $62,574 | 93 | $0 (2020) |
| Depomed, Inc. | $27,825 | 48 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $19,795 | 69 | $0 (2024) |
| West Therapeutics Development, LLC | $12,974 | 21 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $8,666 | 35 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $4,508 | 32 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $3,330 | 14 | $0 (2021) |
| Seagen Inc. | $3,010 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,377 | 41 | Aadi Bioscience, Inc. ($173.65) |
| 2023 | $1,301 | 41 | E.R. Squibb & Sons, L.L.C. ($392.33) |
| 2022 | $1,405 | 50 | Seagen Inc. ($161.55) |
| 2021 | $1,748 | 61 | Incyte Corporation ($290.26) |
| 2020 | $33,210 | 96 | Verastem, Inc. ($26,337) |
| 2019 | $56,297 | 149 | Verastem, Inc. ($52,511) |
| 2018 | $139,504 | 200 | INSYS Therapeutics Inc ($75,677) |
| 2017 | $186,275 | 257 | INSYS Therapeutics Inc ($112,892) |
All Payment Transactions
895 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $32.81 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $33.86 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $54.94 | General |
| 12/09/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | PFIZER INC. | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $30.47 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $35.07 | General |
| Category: Oncology | ||||||
| 10/30/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Immunology | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $117.34 | General |
| Category: Oncology | ||||||
| 10/09/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Helsinn Therapeutics (U.S.), Inc. | AKYNZEO (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug), Stivarga | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Oncology | ||||||
| 09/26/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $40.35 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: ONCOLOGY | ||||||
| 08/19/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $64.50 | General |
| Category: Oncology | ||||||
| 08/15/2024 | PFIZER INC. | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.95 | General |
| 08/13/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Aadi Bioscience, Inc. | Fyarro (Drug) | Food and Beverage | In-kind items and services | $149.46 | General |
| Category: Cancer | ||||||
| 07/11/2024 | Aadi Bioscience, Inc. | Fyarro (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Cancer | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 302 | 410 | $140,112 | $43,758 |
| 2022 | 6 | 199 | 250 | $44,340 | $16,933 |
| 2021 | 12 | 324 | 763 | $57,114 | $24,499 |
| 2020 | 6 | 120 | 179 | $16,042 | $8,579 |
Total Patients
945
Total Services
1,602
Medicare Billing
$93,769
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 174 | 250 | $81,750 | $26,280 | 32.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 25 | 29 | $14,065 | $4,474 | 31.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 36 | $12,384 | $3,707 | 29.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 16 | 16 | $10,080 | $3,102 | 30.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 42 | $9,114 | $2,629 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $6,071 | $1,859 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 24 | $6,648 | $1,707 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 97 | 107 | $20,511 | $7,339 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 27 | $3,605 | $2,656 | 73.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $5,504 | $1,699 | 30.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 21 | 21 | $4,305 | $1,654 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 27 | 28 | $4,084 | $1,448 | 35.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 23 | $3,335 | $1,287 | 38.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 28 | $2,996 | $849.52 | 28.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 104 | 148 | $20,447 | $7,484 | 36.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 44 | 53 | $9,897 | $4,004 | 40.5% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 15 | 20 | $3,380 | $2,704 | 80.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 25 | $3,150 | $2,419 | 76.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 14 | 14 | $4,865 | $1,946 | 40.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 13 | 13 | $5,330 | $1,334 | 25.0% |
| 96417 | Infusion of different chemotherapy drug or substance into a vein up to 1 hour | Office | 2021 | 11 | 20 | $1,600 | $1,280 | 80.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 18 | $1,572 | $1,225 | 77.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 28 | 32 | $2,644 | $843.83 | 31.9% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 12 | 49 | $1,372 | $764.40 | 55.7% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2021 | 12 | 130 | $2,340 | $268.36 | 11.5% |
About Dr. Steven Wong, MD
Dr. Steven Wong, MD is a Hematology & Oncology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275553307.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Wong, MD has received a total of $421,118 in payments from pharmaceutical and medical device companies, with $1,377 received in 2024. These payments were reported across 895 transactions from 71 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($269,955).
As a Medicare-enrolled provider, Wong has provided services to 945 Medicare beneficiaries, totaling 1,602 services with total Medicare billing of $93,769. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location Santa Monica, CA
- Active Since 07/20/2006
- Last Updated 11/27/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1275553307
Products in Payments
- SYNDROS (Drug) $105,506
- SUBSYS (Drug) $83,062
- Copiktra (Drug) $78,849
- TECENTRIQ (Biological) $61,936
- Lazanda (Drug) $40,405
- IMFINZI (Drug) $18,589
- Non-Covered $7,813
- PDR001 (Drug) $3,700
- Tavalisse (Drug) $3,316
- PADCEV (Biological) $2,816
- OPDIVO (Biological) $1,016
- TAGRISSO (Drug) $889.28
- KEYTRUDA (Biological) $885.10
- PADCEV (Drug) $628.03
- Vitrakvi (Drug) $458.27
- ELITEK (Biological) $363.14
- PROVENGE (Drug) $338.42
- Stivarga (Drug) $290.62
- Nucynta (Drug) $279.36
- TAZVERIK (Drug) $238.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Santa Monica
Omid Hamid, M.d, M.D
Hematology & Oncology — Payments: $981,950
Hematology & Oncology $981,950
Steven O'day, M.d, M.D
Hematology & Oncology — Payments: $594,773
Hematology & Oncology $594,773
Silvana Martino, D.o, D.O
Hematology & Oncology — Payments: $179,144
Hematology & Oncology $179,144
Miss. Blanca Ledezma, Msn, Np, MSN, NP
Hematology & Oncology — Payments: $148,836
Hematology & Oncology $148,836
Dr. Arun Singh, M.d, M.D
Hematology & Oncology — Payments: $121,941
Hematology & Oncology $121,941
Dr. William Isacoff, M.d, M.D
Hematology & Oncology — Payments: $108,579
Hematology & Oncology $108,579